Bullish US Stocks With Highest Surge In The Last One Month: $ALT $KNDI $CAPR

*If You Own ALT, KNDI, CAPR Then Click Here to Join Our Community Of Traders

The Market Signal was created as a platform to help investors, if you own (NASDAQ:ALT), (NYSE:KNDI) or (NASDAQ:CAPR) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/Free-Report/NOW
(Click the link above or copy, paste and hit enter in your browser for your report)

Altimmune Partners With Vigene To Advance Its COVID-19 Vaccine Candidate

https://themarketsignal.com/ Free-Report/ALT

(Click the link above or copy, paste and hit enter in your browser for your report)

Over the past month, Altimmune Inc. (NASDAQ:ALT) stock surged 142.72%. The company is scheduled to releases it Q2 2020 and Six months ended June 30 results as well as a business update on August 12, 2020. Altimmune signed an agreement with Vigene Biosciences for the manufacture of its single-dose intranasal vaccine candidate, adCOVID, for COVDID-19. Vigene is a CDMO that focuses on viral infections and will use its capabilities to manufacture AdCOVID. After the recent encouraging pre-clinical data the company is planning to commence the first phase AdCOVID clinical trials in the fourth quarter.

Altimmune CEO, Vipin Garg said that they were pleased to partner with Vigne in advancing AdCOVID into the first phase of clinical trials. He added that the deep experience of Vigene in viral production and their client-focused approach will help facilitate the timeline for AdCOVID's clinical development.

Kandi Technologies Launches New Electric Vehicles In The US

https://themarketsignal.com/ Free-Report/KNDI

(Click the link above or copy, paste and hit enter in your browser for your report)

Kandi Technologies Group Inc. (NASDAQ:KNDI) has also surged in the past month and its stock is up 103.98%. The company will report its Q2 2020 financial results on August 10, 2020, before markets open followed by a conference to discuss the results. Recently the company launched cheap pure electric automobiles in The US the Kandi K23 and K27 models.

The company unveiled a marketing campaign supporting the launch titled "Kandi.Auto Evolution for all" centering around a virtual event expected to kick-off on August 18. Consumers seeking to buy the EVs can make reservations with a $100 refundable deposit with the vehicles expected in Q4 2020.

Capricor Therapeutics To Report Q2 2020 Results On August 6

https://themarketsignal.com/ Free-Report/CAPR

(Click the link above or copy, paste and hit enter in your browser for your report)

Capricor Therapeutics Inc. (NASDAQ:CAPR) has also gained 85.10% over the past month. The company announced that it will report its Q2 financial results for the quarter ended June 30 on August 6, 2020, after market close followed by a conference call to discuss the results and offer a business update. The biotech company could report a YoY increase on lower revenues for the quarter. According to Consensus Estimates the is likely to post a loss of 37 cents per share in the upcoming Q2 results which will be a 37.3% YoY improvement. YoY revenue is expected to drop by 48.8% to around $0.21 million.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market, and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

The post Bullish US Stocks With Highest Surge In The Last One Month: $ALT $KNDI $CAPR appeared first on The Market Signals.

comtex tracking

COMTEX_368974194/2700/2020-08-06T08:37:14

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.